Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Adenylate cyclase 1 Blocking Peptide (AC1641)
Cat.#: ACPP-1641
Specifications
Despition Adenylate cyclase 1 Blocking Peptide SIZE 250 µg Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1067 Recombinant Human CD11b Protein (Fc Tag) (AC1067) 50 µg inquiry ACPP-1471 Human SCG3 Protein (AC1471) 5 µg inquiry ACPP-1357 P2Y12 Blocking Peptide (AC1357) 250 µg inquiry ACPP-1097 Synthetic Nanodisc Human ENTPD2 Protein (AC1097) 10 µg inquiry ACPP-1659 Human Visfatin Protein (AC1659) 5 µg inquiry ACPP-1715 Mouse Acrp30 Protein, HEK (AC1715) 2 µg inquiry ACPP-1321 NPY5R Blocking Peptide (AC1321) 250 µg inquiry ACPP-1447 Human CANX Protein (AC1447) 10 µg inquiry ACPP-1553 Human NRG4 Protein (AC1553) 2 µg inquiry ACPP-1281 ULK1 Blocking Peptide (AC1281) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket